The top 100 stock
market authors
selected for publication
market authors
selected for publication
Allergan Inc. (AGN) ()
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Allergan Inc. (AGN) by latest | most commented
- A Look at the Neural Fair Value Portfolio for Investment Ideas
- Spectrum Pharmaceuticals: Undervalued Growth Company with Strong Late-Stage Pipeline
- Amgen's Better than Expected Portfolio Outlook
- 15 Stocks with the Stamina to Survive This Crisis
- FDA, Clinical Trial Updates: JNJ, INCY, MEDX, CYTX, AGN, PPHM
- Q1 2009 Biotech Earnings Roundup: The Good, the Bad, and the Ugly
- Hedge Fund Eton Park Saw Golden Opportunities in Q109
- Inspire Pharma Still Looks Good After Earnings
- 20 'Bathwater Babies' and 20 'Dogs with Fleas' Stocks for the Week
- FDA Calendar Updates: Botox Rival Approved
- Preview from Europe: Stocks Encounter Car Trouble
- Thursday Options Recap
- Thursday Options Update: VMW, FXI, AGN, WYE, XRT & COH
- Paired Trade: Sell Allergan, Buy Johnson & Johnson
- Updated FDA, Clinical Trial Calendars: Dendreon Releases Results
- IHE: Large-Cap Pharma Continues to Blow Away the S&P 500
- Morphosys: A Biotech Rule Breaker (Part 2)
- Tuesday Options Update: Q, AGN, VIX, LTD, XHB, SYK, IP & TGT
- Monday Options Update: XLF, JPM, C, AGN, RHT, SU, SWY
- Earnings Preview: Allergan
- Cynosure Has Weak Q4, Sparking Possibilities of Takeover
- Hedge Fund Portfolio Tracking: SAC Capital (Steven Cohen), Q3 2008
- Updated FDA Decision Calendar: Five Decisions Before Year-End
- Hedge Fund Tracking: Bruce Kovner's Caxton Associates, Q3 2008
- Johnson & Johnson Steals Mentor Corp.: Who's Next?
- Weekly FDA Calendar Update
- Rigel Pharmaceuticals: Biotech Crisis or Opportunity?
- Earnings Preview: Allergan
- Friday Options Update: MSFT, HBC, DWA, AGN, XLF, C, MS and VIX
- Industry Profile: Cosmetic and Reconstructive Medicine
- Summer Surge for Pharma Powers IHE, but Concerns Remain
- Allergan: When Deals Get Ugly
- Earnings Preview: Allergan
- Roche and Allergan Victorious Over Apotex in Acular LS Dispute
- Credit Suisse Healthier 15: Investors Get the Skinny on Fat Fighters
- Will Wal-Mart Heat Up Chile? Fast Money (6/17/08)
- Wrinkle in Allergan’s Forecast
- Pfizer Should Buy Amgen or Wyeth - Credit Suisse
- Wall Street Breakfast: Must-Know News
- Allergan Drops Unnecessarily on FDA BOTOX Review
- 7 Healthcare Stocks for a Sick Market
-
The Seeking Alpha 100
See all
Seeking Alpha 100 » -
Fastest Climbers
Authors with the largest
increase in followers
in the last 7 days-
1
David Fry
-
2
Philip Davis
-
3
Bill Gross
-
4
Tyler Durden
-
5
TraderMark
Fastest Climbers » -
1
-
Top Commenters
Top commenters,See all
as ranked by their peers
Top Commenters » -
Top Instabloggers
The 100 most activeSee all
Instabloggers.
Top Instabloggers » -
Top StockTalkers
TopSee all
StockTalkers.
Top StockTalkers »
